Salvat

Salvat is a global pharmaceutical company, specialized in the production of pharmaceuticals and provision of services as a contract development and manufacturing organization (CDMO). With a specialized focus on sterile liquids in single-dose vials, we are headquartered in Barcelona, Spain, and have a subsidiary in Miami, US. Our reach extends to over 60 countries worldwide, where we develop, manufacture, and market a diverse range of pharmaceutical products across several therapeutic areas, including ophthalmology, otolaryngology, gastroenterology, and wound care. Through strategic global alliances, we continuously innovate and contribute to enhancing patient care.

Our comprehensive CDMO service solutions: We provide end-to-end, fully integrated drug development and manufacturing solutions that adhere to the highest GMP & FDA standards. Our state-of-the-art facilities and advanced technologies enable us to deliver exceptional products, including:

• Single-dose vials of sterile liquids using Blow-Fill-Seal technology (Rommelag technology). With 7 production lines (2 in Barcelona, 4 in Madrid and 1 in Florida), we can produce over 300M u/year, with fill volumes ranging from 0.20mL to 15mL and batch sizes ranging from 50L to 2000L. Multi-dose bottles of sterile liquids using a bottle filling line (Groninger technology). We can produce over 25M u/year, with fill volumes ranging from 2mL to 15mL and batch sizes ranging from 100L to 2000L.
• Multi-dose non-sterile liquids with batch sizes ranging from 50L to 2000L.
• Solid dosage forms include tablets, capsules, and sachets. We have the capacity to produce over 195M u/year tablets, 100M u/year capsules, and 2.6M u/year sachets. Batch sizes for tablets and capsules range from 100kg to 500kg, while sachets range from 50kg to 250kg. We offer both coated and uncoated tablets, with full serialization and aggregation capabilities.